Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - nebivololum - tabletten - nebivololum 5 mg zu nebivololi hydrochloridum, excipiens pro compresso. - hypertonie und chronische herzinsuffizienz - synthetika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

actavis switzerland ag - nebivololum - tabletten - nebivololum 5 mg ut nebivololi hydrochloridum, excipiens pro compresso. - beta-rezeptorenblocker - synthetik menschlichen

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - liraglutidum - fertigpen (triple-dosis) - liraglutidum 6 mg, dinatrii phosphas dihydricus, propylenglycolum, natrii hydroxidum q.s. ad ph, acidum hydrochloricum q.s. ad ph, phenolum, aqua ad iniectabile ad solutionem pro 1 ml. - antidiabetikum - biotechnologika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - nebivololum - tabletten - nebivololum 5 mg zu nebivololi hydrochloridum 5.45 mg, silica colloidalis anhydrica, magnesium stearas, carmellosum natricum, macrogolum 6000, lactosum monohydricum 192.4 mg, für compresso endwerte. natrium 0,06 mg. - beta-rezeptorenblocker - synthetika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - nebivololum - tabletten - nebivololum 5 mg zu nebivololi hydrochloridum 5.45 mg, silica colloidalis anhydrica, magnesium stearas, carmellosum natricum nur zusammen gehalten, macrogolum 6000, lactosum monohydricum 192.4 mg, für compresso endwerte. natrium 0,3 mg. - beta-rezeptorenblocker - synthetika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - nebivololum - tabletten - nebivololum 5 mg ut nebivololi hydrochloridum 5.45 mg, carmellosum natricum conexum corresp. natrium 0.027 mg, lactosum monohydricum 142 mg, maydis amylum, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, pro compresso. - beta-rezeptorenblocker - synthetika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - nebivololum - tabletten - nebivololum 5 mg zu nebivololi hydrochloridum, lactosum monohydricum 85.96 mg, crospovidonum, poloxamerum 188, povidonum k 30, cellulosum microcristallinum, magnesium stearas, pro compresso. - beta-rezeptorenblocker - synthetika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - insulinum degludecum - injektionslösung - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - insulinum degludecum - injektionslösung - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - insulinum degludecum - injektionslösung - insulinum degludecum 1200 nmol corresp. insulinum degludecum 200 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika